Short course chemotherapy in children suffering from drug resistant tuberculosis

Short course chemotherapy in children suffering from drug resistant tuberculosis

The objective: to study the effect of short course chemotherapy regimens on treatment outcomes in children with drug resistant tuberculosis.Subjects and methods. In 2017-2019, 31 children at the age from 3 to 17 years old, received short course chemotherapy which lasted for 12-15 months. Children of...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. I. Klevno, V. A. Аksenova, A. V. Kazakov, E. B. Kovalevskaya
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2021-03-01
Series:	Туберкулез и болезни лёгких
Subjects:	mdr tuberculosis in children chemotherapy short course
Online Access:	https://www.tibl-journal.com/jour/article/view/1509
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
by: A. О. Mаryandyshev, et al.
Published: (2019-08-01)

Eﬃcacy and safety of short course chemotherapy regimens in older children and adolescents with multiple and extensive drug resistant respiratory tuberculosis
by: L. V. Panova, et al.
Published: (2021-11-01)

Short-Course Chemotherapy Regimens for Treatment of Multiple and Pre-Extensive Drug Resistant Tuberculosis in Combination with Surgery in Older Children and Adolescents
by: E. S. Ovsyankina, et al.
Published: (2024-12-01)

Short course chemotherapy in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkina, et al.
Published: (2020-12-01)

Preventive chemotherapy in children exposed to multiple drug resistant tuberculosis
by: V. A. Аksenova, et al.
Published: (2019-07-01)

Justification of Chemotherapy Duration in Patients with Multiple and Pre-Extensive Drug Resistant Tuberculosis in the Russian Federation
by: A. I. Gayda, et al.
Published: (2023-01-01)

Simulation of Conditions and Results of Implementation of Short-Course Treatment Regimes in Tuberculosis Patients
by: V. S. Burykhin, et al.
Published: (2023-12-01)

EXPERIENCE OF SHORT-COURSE TREATMENT IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. A. Toktogonovа, et al.
Published: (2018-06-01)

Immediate and Postponed Results of Short-Course Chemotherapy Regimens Containing Bedaquiline in Tuberculosis Patients with Multiple Drug Resistance
by: P. N. Golubchikov, et al.
Published: (2023-08-01)

Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)

Medications for Short-Course Chemotherapy of Drug Resistant Tuberculosis and Their Effect on the Host
by: G. N. Mozhokina, et al.
Published: (2022-09-01)

Short course treatment of pulmonary tuberculosis patients suffering from multiple drug resistance. The current situation and future perspectives
by: A. E. Russkikh, et al.
Published: (2021-01-01)

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)

New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01)

Efficacy of standard chemotherapy regimens in children and adolescents suffering from respiratory tuberculosis
by: E. F. Luginova, et al.
Published: (2020-12-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

Specific features of the clinical course and chemotherapy of tuberculosis in children exposed to tuberculosis with different drug resistance patterns
by: M. E. Lozovskaya, et al.
Published: (2019-10-01)

QT-Interval Prolongation in the Treatment of Drug-Resistant Tuberculosis
by: A. V. Kukurika
Published: (2024-03-01)

A Unique Case of Cure of the Patient with Disseminated Bilateral Fibrous Cavernous Pulmonary Tuberculosis with Extensive Drug Resistance after 18 Years of Treatment Failures
by: O. G. Komissarova, et al.
Published: (2024-12-01)

Non-Injection Chemotherapy Regimens for Drug Resistant Tuberculosis in Children and Adolescents
by: V. A. Aksenova, et al.
Published: (2023-12-01)

Potential targets for the new anti-tuberculosis drug of the diarylquinoline group thiozonide
by: А. Yu. Savchenko, et al.
Published: (2025-06-01)

IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. G. Samoylova, et al.
Published: (2016-09-01)

Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial
by: Xubin Zheng, et al.
Published: (2023-12-01)

Tolerability of individual chemotherapy regimens in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkinа, et al.
Published: (2021-04-01)

Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacterium tuberculosis</i>
by: А. Yu. Savchenko, et al.
Published: (2024-01-01)

Algorithm for assigning different 6-month short-term chemotherapy regimens in patients with drug-resistant tuberculosis: how to make the right choice for the clinician
by: Yu.I. Feshchenko, et al.
Published: (2025-06-01)

Is a 6-month Treatment for Isoniazid-resistant Tuberculosis Effective?
by: A. I. Kulizhskaya, et al.
Published: (2022-03-01)

The course of multidrug-resistant pulmonary tuberculosis in HIV-infected people with COVID-19
by: O. M. Raznatovska, et al.
Published: (2022-09-01)

Safety and Efficacy of Multiple Drug Resistant Tuberculosis Treatment in Patients with Different HIV Statuses
by: S. Yu. Degtyareva, et al.
Published: (2022-02-01)

Efficacy of Various Approaches to Treatment of Patients with Isoniazid Resistant Pulmonary Tuberculosis
by: I. A. Burmistrova, et al.
Published: (2023-12-01)

Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis
by: I. A. Burmistrova, et al.
Published: (2019-09-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

Frequency and Structure of Drug Resistance of M. tuberculosis in Pulmonary and Extrapulmonary Tuberculosis
by: P. K. Yablonskiy, et al.
Published: (2024-03-01)

Experience of using a combination mucoactive drug during chemotherapy in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2020-08-01)

The Role of Risk Factors in the Development of Tuberculosis in Children Exposed to Rifampicin Resistant Tuberculosis
by: N. A. Nikiforenko, et al.
Published: (2021-08-01)

Deeplex Sequencing of Mycobacterium Tuberculosis Strains Isolated in Kosovo
by: Rrezarta Bajrami, et al.
Published: (2024-12-01)

HIV infection and multiple drug resistant tuberculosis: the frequency of co-infection and treatment efficacy
by: O. V. Filinyuk, et al.
Published: (2021-03-01)

THE NIDUS OF TUBERCULOUS INFECTION AS A RISK FACTOR OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN CHILDREN
by: V. A. Аksenovа, et al.
Published: (2018-01-01)

POST-OPERATIVE CHEMOTHERAPY OF RESPIRATORY TUBERCULOSIS IN THE OLDER CHILDREN AND ADOLESCENTS
by: L. V. Pаnovа, et al.
Published: (2017-05-01)

Determination of Duration of the Intensive Phase of Chemotherapy for Respiratory Tuberculosis in Children without Bacterial Excretion and at No Risk of Multiple and Extensive Drug Resistance
by: M. F. Gubkinа, et al.
Published: (2021-07-01)